I believe the reason they haven't committed to a windup (yet) is they need a unit holder vote to deviate from their current objectives.
Not a fantastic price for their flagship asset, but with assets still earning until settlement I see a 20% return over the next 9 months (capital and earnings), which is pretty decent. Agree there is an element of risk though, will be looking to add the next few days
- Forums
- ASX - By Stock
- AOF
- Ann: Exchange of Valentine Avenue Parramatta
Ann: Exchange of Valentine Avenue Parramatta, page-7
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AOF (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.23 |
Change
0.005(0.41%) |
Mkt cap ! $201.3M |
Open | High | Low | Value | Volume |
$1.22 | $1.23 | $1.21 | $356.0K | 294.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9183 | $1.23 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.23 | 20000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9183 | 1.225 |
1 | 22500 | 1.210 |
2 | 54302 | 1.205 |
8 | 68966 | 1.200 |
1 | 29103 | 1.195 |
Price($) | Vol. | No. |
---|---|---|
1.230 | 20000 | 2 |
1.235 | 36250 | 2 |
1.250 | 48477 | 2 |
1.260 | 1250 | 1 |
1.270 | 1250 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
AOF (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online